FAAM EUROBAT 2024
BackOAS1 - Allergen immunotherapy
Thursday 21 Nov, 15:30 PM -
17:00 PM Athens, Greece
Omega
Oral Abstract Session
Abstract Text
15:30
OA-05
Subcutaneous administration of a novel Virus-like Particle Vaccine for the Treatment of Peanut Allergy is safe and well tolerated
Abstract Text
15:42
OA-01
Evolution of pediatric patients with casein-specific IgE values>100 KU/L undergoing cow's milk oral immunotherapy
Abstract Text
15:54
OA-02
Changes in IgG4 and IgE epitope binding profile are greater with sublingual than oral immunotherapy in milk-allergic children, and correspond to efficacy outcomes
Abstract Text
16:06
OA-03
Predicting treatment response to oral immunotherapy in peanut-allergic children using multi-omics risk scores
Abstract Text
16:18
OA-04
Boiled peanut or roasted peanut for oral immunotherapy: Results from the BOPI-2 Study
Abstract Text
16:30
OA-06
A delivery platform for food allergy immunotherapy based on dissolvable microneedle array patches with ovalbumin mesoporous silica nanoparticles
Abstract Text
16:42
OA-07
Cracking the Code: Immunological Changes Leading to Raw Egg Tolerance During Immunotherapy with Cooked Egg
